United States· US:68071-3635_2abca736-08a4-e465-e063-6294a90a0b52
Minocycline Hydrochloride
A minocycline product containing minocycline hydrochloride, registered in United States by NuCare Pharmaceuticals,Inc.. The same ATC class is registered in 10 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Minocycline is registered in 10 of 19 countries.
Countries holding a registration under ATC J01AA08 (minocycline), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 4 of them publish a price we can compare per daily dose
Minocycline · ATC J01AA08
10 / 19 countries
- Belgiumprice
- Canada
- Germany
- Ireland
- Japan
- Netherlands
- Norwayprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- MINOCYCLINE HYDROCHLORIDE
- Manufacturer
- NuCare Pharmaceuticals,Inc.
- Country
- United States (US)
- ATC code
- J01AA08
- ATC class
- Minocycline
- Defined daily dose
- 0.2 g, O
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc1168071-3635-3
- ndc11680713635330 CAPSULE in 1 BOTTLE (68071-3635-3)
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
367 interactions on record for minocycline.
Graded by severity as the source publishes them — 15 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Minocycline · interactions on record
367 records
- 15 severe
- 142 moderate
- 28 minor
- 128 info
Most severe, free to view
- MipomersenC10AX11severe
- LomitapideC10AX12severe
- AcitretinD05BB02severe
- IsotretinoinD10AD04severe
54 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Minocycline in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumMinocycline EG 50 mgEG
- CanadaMINOCYCLINEAA PHARMA INC
- United KingdomAknemin 50 capsulesAlmirall Ltd
- NorwayMinocinMelinta Therapeutics
- NetherlandsMinocycline Aurobindo 100 mg, omhulde tablettenAurobindo Pharma B.V.
- GermanyMinoplusChephasaar Chemisch-Pharmazeutische Fabrik Gmbh
- IrelandMinocin SA 100 mg Modified Release CapsulesViatris Healthcare Limited
- FranceMYNOCINE 100 mg, géluleLABORATOIRE XO
Authorised across Europe · EMA
The same active substance is authorised in 16 EEA countries. Names it is sold under:
- Austria · Minostad
- Belgium · Klinotab, Mino-50
- Bulgaria · Миноциклин Екофарм
- Cyprus · Minaxen
- Germany · Minoplus, Skid
- Spain · Minocin Vía Oral
- France · Kyno, Mynocine
- United Kingdom (Northern Ireland) · Dentomycin, Minocin Mr
- Greece · Minocin
- Ireland · Minocin Sa, Minosil
- Italy · Minocin
- Luxembourg · Klinotab, Mino
- Malta · Minaxen
- Netherlands · Minocycline Eurogenerics, Minocycline Hydrochloride Dihydrate Aurobindo
- Portugal · Cipancin, Minocin
- Romania · Minoz Ep
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d3f72f0a-1bcf-4f54-b106-42f03f3987d9 GET /v1/drugs/d3f72f0a-1bcf-4f54-b106-42f03f3987d9?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "50",
"substance": "MINOCYCLINE HYDROCHLORIDE",
"productndc": "68071-3635",
"dosage_form": "CAPSULE",
"dea_schedule": null,
"strength_unit": "mg/1",
"application_number": "ANDA065062",
"marketing_category": "ANDA"
}See everything about minocycline.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.